Lilley & Co’s Merck MRK Stock Holding History

Lilley & Co’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-4,143	Closed	-$224K	–	107
2014 Q1	$224K	Buy	+4,143	New	+$215K	0.1%	101

Other funds holding MRK

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Lilley & Co's MRK Position: Q2 2014 in Review

Lilley & Co sold out of Merck (MRK) in Q2 2014, closing a stake of 4,143 shares — an estimated $224K sold.

Lilley & Co first reported a position in MRK in Q1 2014 and held it in 1 quarter. The position peaked at $224K in Q1 2014. 1,619 funds tracked by Wall St. Rank hold MRK as of Q2 2014.

Lilley & Co reported no remaining Merck position as of Q2 2014 after selling out during the quarter.
Lilley & Co sold 4,143 Merck shares in Q2 2014, an estimated $224K.
Lilley & Co first reported a position in Merck in Q1 2014 and held it in 1 quarter.
Lilley & Co's Merck position peaked at $224K in Q1 2014.
1,619 funds tracked by Wall St. Rank held Merck as of Q2 2014.

Based on Lilley & Co's 13F filing for Q2 2014, filed 14 Jul 2014.